Multi-Drug Resistance in Cancer /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2010.
|
| Edition: | 1st ed. 2010. |
| Series: | Methods in Molecular Biology,
596 |
| Subjects: |
Table of Contents:
- Multidrug Resistance in Cancer
- Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets
- Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer
- Mechanisms of Multidrug Resistance in Cancer
- Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells
- Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
- Flow Cytometric Evaluation of Multidrug Resistance Proteins
- Targeted Chemotherapy in Drug-Resistant Tumors, Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer, and Emerging Role of Pgp in Neurodegenerative Diseases
- Epigenetic Regulation of Multidrug Resistance 1 Gene Expression: Profiling CpG Methylation Status Using Bisulphite Sequencing
- Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics
- Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1
- Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes
- Drug Ratio-Dependent Antagonism: A New Category of Multidrug Resistance and Strategies for Its Circumvention
- Reversing Agents for ATP-Binding Cassette Drug Transporters
- Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors
- Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation
- Examination of CYP3A and P-Glycoprotein-Mediated Drug-Drug Interactions Using Animal Models
- Generating Inhibitors of P-Glycoprotein: Where to, Now?
- Immunosuppressors as Multidrug Resistance Reversal Agents
- Overcoming Multidrug Resistance by RNA Interference
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology.